Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • GTC-AF Lawyers merger terminated amid leadership resignations and governance cracks
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • GTC-AF Lawyers merger terminated amid leadership resignations and governance cracks
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • GTC-AF Lawyers merger terminated amid leadership resignations and governance cracks
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • GTC-AF Lawyers merger terminated amid leadership resignations and governance cracks
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • GTC-AF Lawyers merger terminated amid leadership resignations and governance cracks
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • AF Legal records first loss in 15 months due to major employee turnover and fewer cases to work
    AF Legal records first loss in 15 months due to major employee turnover and fewer cases to work
    • News

  • From Families to Funerals: AF Legal to acquire will disputes division of Armstrong Legal for $3.7m
    From Families to Funerals: AF Legal to acquire will disputes division of Armstrong Legal for $3.7m
    • News

  • Raiz a glass as micro investment platform reports 23.2% revenue uptick and edges closer to profit
    Raiz a glass as micro investment platform reports 23.2% revenue uptick and edges closer to profit
    • News

  • After selling US arm to focus on Australia, PointsBet gets the winning ball rolling
    After selling US arm to focus on Australia, PointsBet gets the winning ball rolling
    • News

  • Yowie gets AFL, Rugby League and Bluey merchandising contracts but struggles with sales in the US
    Yowie gets AFL, Rugby League and Bluey merchandising contracts but struggles with sales in the US
    • News

  • IPO Watch: Gefen Technologies to list on ASX with digital marketing platform for agents
    • News

    IPO Watch: Gefen Technologies to list on ASX with digital marketing platform for agents

    With initial plans to list in the Australian market last year furloughed by the pandemic, Israeli tech company Gefen Technologies is finally joining the dozen Israeli companies on the ASX, having closed their $25 million IPO at the end of last month. Israel is renowned for their ‘start up culture’, especially in tech, having produced

    Read More
    Public
  • White whale secured as iSelect adds Bupa to platform for health insurance comparison
    • News

    White whale secured as iSelect adds Bupa to platform for health insurance comparison

    In a deal that has taken many years to execute, online price comparison company iSelect (ASX: ISU) has finally secured an affiliate marketing deal to promote Bupa, Canstar’s ‘Outstanding Value Health Insurance’ National Award winner for 13 years running. Given the public accolades won over the past decade as a household name across Australia, it’s

    Read More
    Public
  • How Noxopharm is overhauling the way we approach cancer treatment
    • News

    How Noxopharm is overhauling the way we approach cancer treatment

    Traditional chemotherapy and radiotherapy have long been the standard of care for cancer treatment, but it’s no secret that there are numerous, debilitating side effects to a patient’s physical and mental health. Both are oftentimes ineffective with several cancers exhibiting poor responsiveness to traditional treatment.  Clinical-stage drug development company Noxopharm (ASX: NOX) is addressing this

    Read More
    Public
  • Crowd Media showcases disruptive potential with 100% digitally produced doppelganger
    • News

    Crowd Media showcases disruptive potential with 100% digitally produced doppelganger

    Within their latest Proof of Concept, artificial intelligence company Crowd Media (ASX: CM8) has showcased the interactive capabilities of its conversational commerce platform where digital avatars of celebrities and influencers can interact with fans, offer advice and unlock new commercial opportunities. In their latest public release of ‘Digital Dom’ – a 100% synthetically produced version

    Read More
    Public
  • Epsilon to provide medicinal cannabis for clinical study in children
    • News

    Epsilon to provide medicinal cannabis for clinical study in children

    A hot topic in medical research at the moment, medicinal cannabis studies are being carried out for seemingly any and all ailments. One such trial being run by the Murdoch Children’s Research Institute (MCRI) is extending efficacy studies of cannabidiol medicine to children with intellectual disability that exhibit severe behavioural problems. To facilitate these studies,

    Read More
    Public
  • Prairie Mining commences $1.5 billion litigation against Republic of Poland
    • News

    Prairie Mining commences $1.5 billion litigation against Republic of Poland

    The market cap of Prairie Mining (ASX: PDZ) could increase 30x if the small cap mining company is successful in its case against the Republic of Poland having lodged its £806 million Statement of Claim against the nation for depriving it of its investments. The claim (which is equivalent to AUD $1.5 billion or USD

    Read More
    Public
  • Pharmaxis Investor Briefing – Cancer Treatment Clinical Trials
    • News

    Pharmaxis Investor Briefing – Cancer Treatment Clinical Trials

    On 4 June, 2021, Pharmaxis (ASX: PXS) hosted an investor briefing with CEO Gary Phillips to update investors on recent achievements and future plans, plus a Q&A with attendees. Topics discussed in the briefing and question time included: Clinical trial stage progress and timelines; Anticipated news flow for 2021-2022; Commercial opportunities being explored in collaborationRead More
    Public
  • Mad Paws to acquire Waggly Club, our office dog approves
    • News

    Mad Paws to acquire Waggly Club, our office dog approves

    Feeding our office dog and many other pups Australia wide with their subscription meal service, Dinner Bowl, it’s safe to say Mad Paws (ASX: MPA) understands the subscription market. The Company has today announced the acquisition of one of Australia’s largest dog treats and toys subscription business, Waggly Club. Since its inception when founded by

    Read More
    Public
  • Delta Drones secures 5-year extension from South32 as mining tech undergoes transformation
    • News

    Delta Drones secures 5-year extension from South32 as mining tech undergoes transformation

    Where costs to survey expansive land masses has always been the largest impediment to mining discoveries, the evolution of drone technology is playing a big role in lowering those costs as evidenced by the 5-year extension secured by Delta Drone (ASX: DLT) from South32, one of the world’s largest resource companies. The contract extension continues

    Read More
    Public
  • Strong sales continue for ZOLEO satellite messaging device
    • News

    Strong sales continue for ZOLEO satellite messaging device

    Beam Communications (ASX: BCC) is enjoying the continued success of their satellite messaging device ZOLEO and has announced that they have received new orders for 22,000 of them. Sales have remained strong since ZOLEO’s launch in December 2019 with the device filling a previously unmet need for an affordable, compact and clever satellite messaging device.

    Read More
    Public
  • «
  • ‹
  • 238
  • 239
  • 240
  • 241
  • 242
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.